109 related articles for article (PubMed ID: 12927856)
1. Novel diphenylalkyl piperazine derivatives with high affinities for the dopamine transporter.
Kimura M; Masuda T; Yamada K; Mitani M; Kubota N; Kawakatsu N; Kishii K; Inazu M; Kiuchi Y; Oguchi K; Namiki T
Bioorg Med Chem; 2003 Sep; 11(18):3953-63. PubMed ID: 12927856
[TBL] [Abstract][Full Text] [Related]
2. Syntheses of novel diphenyl piperazine derivatives and their activities as inhibitors of dopamine uptake in the central nervous system.
Kimura M; Masuda T; Yamada K; Mitani M; Kubota N; Kawakatsu N; Kishii K; Inazu M; Kiuchi Y; Oguchi K; Namiki T
Bioorg Med Chem; 2003 Apr; 11(8):1621-30. PubMed ID: 12659747
[TBL] [Abstract][Full Text] [Related]
3. Antioxidative activities of novel diphenylalkyl piperazine derivatives with high affinities for the dopamine transporter.
Kimura M; Masuda T; Yamada K; Kawakatsu N; Kubota N; Mitani M; Kishii K; Inazu M; Kiuchi Y; Oguchi K; Namiki T
Bioorg Med Chem Lett; 2004 Aug; 14(16):4287-90. PubMed ID: 15261288
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909).
Zhang Y; Rothman RB; Dersch CM; de Costa BR; Jacobson AE; Rice KC
J Med Chem; 2000 Dec; 43(25):4840-9. PubMed ID: 11123994
[TBL] [Abstract][Full Text] [Related]
5. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
Dutta AK; Xu C; Reith ME
J Med Chem; 1998 Aug; 41(17):3293-7. PubMed ID: 9703474
[TBL] [Abstract][Full Text] [Related]
6. Efficient asymmetric syntheses, determination of absolute configurations and biological activities of 1-[4,4-bis(4-fluorophenyl)butyl]-4-[2-hydroxy-3-(phenylamino)propyl]piperazine as a novel potent dopamine uptake inhibitor in the central nervous system.
Kimura M; Masuda T; Yamada K; Mitani M; Kubota N; Kawakatsu N; Kishii K; Inazu M; Kiuchi Y; Oguchi K; Namiki T
Bioorg Med Chem; 2004 Jun; 12(11):3069-78. PubMed ID: 15142566
[TBL] [Abstract][Full Text] [Related]
7. Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine.
Hsin LW; Dersch CM; Baumann MH; Stafford D; Glowa JR; Rothman RB; Jacobson AE; Rice KC
J Med Chem; 2002 Mar; 45(6):1321-9. PubMed ID: 11882001
[TBL] [Abstract][Full Text] [Related]
8. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues.
Husbands SM; Izenwasser S; Kopajtic T; Bowen WD; Vilner BJ; Katz JL; Newman AH
J Med Chem; 1999 Oct; 42(21):4446-55. PubMed ID: 10543888
[TBL] [Abstract][Full Text] [Related]
10. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
Matecka D; Rothman RB; Radesca L; de Costa BR; Dersch CM; Partilla JS; Pert A; Glowa JR; Wojnicki FH; Rice KC
J Med Chem; 1996 Nov; 39(24):4704-16. PubMed ID: 8941383
[TBL] [Abstract][Full Text] [Related]
11. Oxygenated analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents.
Lewis DB; Matecka D; Zhang Y; Hsin LW; Dersch CM; Stafford D; Glowa JR; Rothman RB; Rice KC
J Med Chem; 1999 Dec; 42(24):5029-42. PubMed ID: 10585212
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter.
Simoni D; Rossi M; Bertolasi V; Roberti M; Pizzirani D; Rondanin R; Baruchello R; Invidiata FP; Tolomeo M; Grimaudo S; Merighi S; Varani K; Gessi S; Borea PA; Marino S; Cavallini S; Bianchi C; Siniscalchi A
J Med Chem; 2005 May; 48(9):3337-43. PubMed ID: 15857139
[TBL] [Abstract][Full Text] [Related]
13. Novel tropane-based irreversible ligands for the dopamine transporter.
Zou MF; Kopajtic T; Katz JL; Wirtz S; Justice JB; Newman AH
J Med Chem; 2001 Dec; 44(25):4453-61. PubMed ID: 11728190
[TBL] [Abstract][Full Text] [Related]
14. Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors.
Matecka D; Lewis D; Rothman RB; Dersch CM; Wojnicki FH; Glowa JR; DeVries AC; Pert A; Rice KC
J Med Chem; 1997 Feb; 40(5):705-16. PubMed ID: 9057857
[TBL] [Abstract][Full Text] [Related]
15. Expansion of structure-activity studies of piperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) compounds by altering substitutions in the N-benzyl moiety and behavioral pharmacology of selected molecules.
Dutta AK; Davis MC; Fei XS; Beardsley PM; Cook CD; Reith ME
J Med Chem; 2002 Jan; 45(3):654-62. PubMed ID: 11806716
[TBL] [Abstract][Full Text] [Related]
16. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.
Agoston GE; Wu JH; Izenwasser S; George C; Katz J; Kline RH; Newman AH
J Med Chem; 1997 Dec; 40(26):4329-39. PubMed ID: 9435902
[TBL] [Abstract][Full Text] [Related]
17. Highly selective, novel analogs of 4-[2-(diphenylmethoxy)ethyl]- 1-benzylpiperidine for the dopamine transporter: effect of different aromatic substitutions on their affinity and selectivity.
Dutta AK; Coffey LL; Reith ME
J Med Chem; 1997 Jan; 40(1):35-43. PubMed ID: 9016326
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and dopamine transporter affinity of chiral 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(2-hydroxypropyl)piperazines as potential cocaine abuse therapeutic agents.
Hsin LW; Prisinzano T; Wilkerson CR; Dersch CM; Horel R; Jacobson AE; Rothman RB; Rice KC
Bioorg Med Chem Lett; 2003 Feb; 13(3):553-6. PubMed ID: 12565970
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.
Choi SW; Elmaleh DR; Hanson RN; Fischman AJ
J Med Chem; 1999 Sep; 42(18):3647-56. PubMed ID: 10479296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
